Market Research Logo

Global Clinical Decision Support Systems Market Insights, Opportunity, Analysis, Market Shares And Forecast 2016 – 2022

Global Clinic Decision Support System market is expected to grow at attractive 12.22% from 2016 to 2022. It is anticipated to grow by US $ 1,520.1 million by 2022 from US $ 865.3 million in 2016. The global clinic decision support system market is broadly segmented on the basis of applications such as (conventional clinical decision support systems, advanced clinical decision support systems), component such as(software, hardware and services) , delivery mode such as(web-based clinical decision support systems, on- based clinical decision support systems, cloud- based clinical decision support systems) , product such as(as standalone clinical decision support systems, integrated clinical decision support systems), type such as (diagnostic clinical decision support systems, and therapeutic clinical decision support systems), model such as (knowledge-based clinical decision support systems, non- knowledge-based clinical decision support systems) and user interactivity such as (active clinical decision support systems, and passive clinical decision support systems) and geographically. on the basis of applications, market is segmented by such as. on the basis of component such as. On the basis of delivery mode like. On the basis of product such.

Advanced healthcare systems contains quality products and services. By 2020, there is a huge demand of healthcare IT market which is projected to reach around US $104.5 billion. Due to the increment of chronic diseases, the number of patient is increasing so they want the home healthcare services. Nearly 6.78 million in US, home healthcare services are needed by patient. Electronic Health Records (EHR) is anticipated to reach US $26.82 billion in 2022 due to huge demand of integrated information systems in the field of healthcare systems. Advanced healthcare systems basically based on cloud-based computing and interoperable system. It is one of the key major driver for increasing advancement in healthcare systems. For example- Telehealth and telecommunication led the around 45% of the market share in 2015 period.

On the basis of geography, the regional segmentation includes the present and predicted demand for North America, Asia Pacific, Europe, Latin America, Middle East and Africa with its added separation into major countries including U.S. Germany, U.K., China, Japan, France, India and Brazil.

Asia-Pacific healthcare IT market is anticipated to gain highest share at around US $19.36 billion by 2020. Due to increasing health care expenditure, and increasing disposable income is the reason for growth of healthcare IT market. Due to health problems of the ageing populations showing the greatest challenges as well as rising complexity of the health sector and servicing organizations. Many of the healthcare systems has now become costly and complex due to social relevance. Mainly, the problem arises in the underdeveloped general public health systems, huge expenditure on healthcare systems, inadequate medical training and service delivery.

There are many of restrain which hinder the CDSS market such as need for huge investment, infrastructure, scarcity of healthcare infrastructure in emerging countries and due to deficiency of skilled workforce.

The key players of the global CDSS Market include Allscripts Healthcare Solutions Inc. Cerner Corporation, Zynx Health Incorporated, International Business Machine Corporation, Siemens AG, RELX Group PLC, Epic Systems Corporation, Meditech, THERMO SCIENTIFIC,WOLTERS KLUWER HEALTH General Electric Company, McKesson Corporation, and Wolters Kluwer.
Please note: The delivery time for the electronic version of this report is between 1-3 business days to allow the preparation of an updated version prior to dispatch.


1. INTRODUCTION
1.1. EXECUTIVE SUMMARY
1.2. MARKET SCOPE
2. MARKET OVERVIEW
2.1. GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET: EVOLUTION & TRANSITION
2.2. INDUSTRY STRUCTURE
2.3. MANUFACTURING PROCESS
2.4. REGULATORY FRAMEWORK
2.5. TOTAL MARKET ANALYSIS
2.5.1. TOP 5 FINDINGS
2.5.2. TOP 5 OPPORTUNITY MARKETS
2.5.3. TOP 5 COMPANIES
2.5.4. TOP 3 COMPETITIVE STRATEGIES
2.6. ESTIMATION ANALYSIS
2.7. STRATEGIC ANALYSIS
2.7.1. INVESTMENT VS. ADOPTION MODEL
2.7.2. 360 DEGREE INDUSTRY ANALYSIS
2.7.3. PORTERS 5 FORCE MODEL
2.7.4. SEE-SAW ANALYSIS
2.7.5. CONSUMER ANALYSIS AND KEY BUYING CRITERIA
2.7.6. GAP ANALYSIS
2.8. COMPETITIVE ANALYSIS
2.8.1. MARKET SHARE ANALYSIS
2.8.2. TOP COMPANY ANALYSIS
2.9. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS
2.9.1. INVESTMENT OPPORTUNITIES BY REGIONS
2.9.2. OPPORTUNITIES IN EMERGING APPLICATIONS
2.9.3. INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT
3. MARKET DETERMINANTS
3.1. MARKET DRIVERS& MARKET IMPACT
3.1.1. INCREASING GOVERNMENT SUPPORT
3.1.2. INCREASING DEMAND
3.1.3. HIGH OCCURRENCE OF CHRONIC DISEASES
3.1.4. INCREASING INCIDENCE OF MEDICATION BLUNDERS
3.1.5. GROWING USAGE OF BIG DATA AND M-HEALTH TOOLS
3.2. MARKET RESTRAINTS
3.2.1. HUGE INVESTMENT IN IT INFRASTRUCTURE
3.2.2. DEFICIENCY OF SKILLED WORKFORCE
3.2.3. SCARCITY OF HEALTHCARE INFRASTRUCTURE
3.3. MARKET OPPORTUNITIES
3.3.1. EMERGING COUNTRIES FOR HEALTHCARE IT
3.3.2. CDSS MARKET GROWTH ACROSS GLOBALLY
3.3.3. TECHNOLOGICAL ADVANCEMENT & INNOVATIONS
3.4. MARKET CHALLENGES
3.4.1. DEFICIENCY OF SKILLED IT PROFESSIONALS
4. MARKET SEGMENTATION
4.1. GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET BY TYPE
4.1.1. MARKET DEFINITION AND SCOPE
4.1.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.1.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.1.4. OPPORTUNITY MATRIX
4.1.5. MARKET SEGMENTATION BY TECHNOLOGY 2014-2022 ($ MILLION)
4.1.5.1. DIAGNOSTIC CLINICAL DECISION SUPPORT SYSTEMS
4.1.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
4.1.5.1.3. APPLICATION
4.1.5.1.4. TOP PLAYERS & KEY PRODUCTS
4.1.5.1.5. REGIONAL ANALYSIS 2014-2022 ($ MILLION)
4.1.5.1.6. KEY CONCLUSIONS
4.1.5.2. THERAPEUTIC CLINICAL DECISION SUPPORT SYSTEMS
4.1.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
4.1.5.2.3. APPLICATION
4.1.5.2.4. TOP PLAYERS & KEY PRODUCTS
4.1.5.2.5. REGIONAL ANALYSIS 2014-2022 ($ MILLION)
4.1.5.2.6. KEY CONCLUSIONS
4.2. GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET BY PRODUCT
4.2.1. MARKET DEFINITION AND SCOPE
4.2.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.2.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.2.4. OPPORTUNITY MATRIX
4.2.5. MARKET SEGMENTATION BY TECHNOLOGY 2014-2022 ($ MILLION)
4.2.5.1. STANDALONE CLINICAL DECISION SUPPORT SYSTEMS
4.2.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
4.2.5.1.3. APPLICATION
4.2.5.1.4. TOP PLAYERS & KEY PRODUCTS
4.2.5.1.5. REGIONAL ANALYSIS 2014-2022 ($ MILLION)
4.2.5.1.6. KEY CONCLUSIONS
4.2.5.2. INTEGRATED CLINICAL DECISION SUPPORT SYSTEM
4.2.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
4.2.5.2.3. APPLICATION
4.2.5.2.4. TOP PLAYERS & KEY PRODUCTS
4.2.5.2.5. REGIONAL ANALYSIS 2014-2022 ($ MILLION)
4.2.5.2.6. KEY CONCLUSIONS
4.3. GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET BY MODEL
4.3.1. MARKET DEFINITION AND SCOPE
4.3.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.3.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.3.4. OPPORTUNITY MATRIX
4.3.5. MARKET SEGMENTATION BY TECHNOLOGY 2014-2022 ($ MILLION)
4.3.5.1. KNOWLEDGE-BASED CLINICAL DECISION SUPPORT SYSTEMS
4.3.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
4.3.5.1.3. APPLICATION
4.3.5.1.4. TOP PLAYERS & KEY PRODUCTS
4.3.5.1.5. REGIONAL ANALYSIS 2014-2022 ($ MILLION)
4.3.5.1.6. KEY CONCLUSIONS
4.3.5.2. NON-KNOWLEDGE-BASED CLINICAL DECISION SUPPORT SYSTEMS
4.3.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
4.3.5.2.3. APPLICATION
4.3.5.2.4. TOP PLAYERS & KEY PRODUCTS
4.3.5.2.5. REGIONAL ANALYSIS 2014-2022 ($ MILLION)
4.3.5.2.6. KEY CONCLUSIONS
4.4. GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET BY USER INTERACTIVITY
4.4.1. MARKET DEFINITION AND SCOPE
4.4.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.4.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.4.4. OPPORTUNITY MATRIX
4.4.5. MARKET SEGMENTATION BY TECHNOLOGY 2014-2022 ($ MILLION)
4.4.5.1. ACTIVE CLINICAL DECISION SUPPORT SYSTEMS
4.4.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.4.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
4.4.5.1.3. APPLICATION
4.4.5.1.4. TOP PLAYERS & KEY PRODUCTS
4.4.5.1.5. REGIONAL ANALYSIS 2014-2022 ($ MILLION)
4.4.5.1.6. KEY CONCLUSIONS
4.4.5.2. PASSIVE CLINICAL DECISION SUPPORT SYSTEMS
4.4.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.4.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
4.4.5.2.3. APPLICATION
4.4.5.2.4. TOP PLAYERS & KEY PRODUCTS
4.4.5.2.5. REGIONAL ANALYSIS 2014-2022 ($ MILLION)
4.4.5.2.6. KEY CONCLUSIONS
4.5. GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET BY APPLICATION
4.5.1. MARKET DEFINITION AND SCOPE
4.5.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.5.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.5.4. OPPORTUNITY MATRIX
4.5.5. MARKET SEGMENTATION BY TECHNOLOGY 2014-2022 ($ MILLION)
4.5.5.1. ADVANCED CLINICAL DECISION SUPPORT SYSTEMS
4.5.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.5.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
4.5.5.1.3. APPLICATION
4.5.5.1.4. TOP PLAYERS & KEY PRODUCTS
4.5.5.1.5. REGIONAL ANALYSIS 2014-2022 ($ MILLION)
4.5.5.1.6. KEY CONCLUSIONS
4.5.5.2. CONVENTIONAL CLINICAL DECISION SUPPORT SYSTEMS
4.5.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.5.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
4.5.5.2.3. APPLICATION
4.5.5.2.4. TOP PLAYERS & KEY PRODUCTS
4.5.5.2.5. REGIONAL ANALYSIS 2014-2022 ($ MILLION)
4.5.5.2.6. KEY CONCLUSIONS
4.6. GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET BY COMPONENT
4.6.1. MARKET DEFINITION AND SCOPE
4.6.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.6.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.6.4. OPPORTUNITY MATRIX
4.6.5. MARKET SEGMENTATION BY TECHNOLOGY 2014-2022 ($ MILLION)
4.6.5.1. SOFTWARE
4.6.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.6.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
4.6.5.1.3. APPLICATION
4.6.5.1.4. TOP PLAYERS & KEY PRODUCTS
4.6.5.1.5. REGIONAL ANALYSIS 2014-2022 ($ MILLION)
4.6.5.1.6. KEY CONCLUSIONS
4.6.5.2. HARDWARE
4.6.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.6.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
4.6.5.2.3. APPLICATION
4.6.5.2.4. TOP PLAYERS & KEY PRODUCTS
4.6.5.2.5. REGIONAL ANALYSIS 2014-2022 ($ MILLION)
4.6.5.2.6. KEY CONCLUSIONS
4.6.5.3. SERVICES
4.6.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.6.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
4.6.5.3.3. APPLICATION
4.6.5.3.4. TOP PLAYERS & KEY PRODUCTS
4.6.5.3.5. REGIONAL ANALYSIS 2014-2022 ($ MILLION)
4.6.5.3.6. KEY CONCLUSIONS
4.7. GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET BY DELIVERY MODE
4.7.1. MARKET DEFINITION AND SCOPE
4.7.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.7.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.7.4. OPPORTUNITY MATRIX
4.7.5. MARKET SEGMENTATION BY APPLICATION 2014-2022 ($ MILLION)
4.7.5.1. CLOUD-BASED CLINICAL DECISION SUPPORT SYSTEMS
4.7.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.7.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
4.7.5.1.3. APPLICATION
4.7.5.1.4. TOP PLAYERS & KEY PRODUCTS
4.7.5.1.5. REGIONAL ANALYSIS 2014-2022 ($ MILLION)
4.7.5.1.6. KEY CONCLUSIONS
4.7.5.2. ON-PREMISE CLINICAL DECISION SUPPORT SYSTEMS
4.7.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.7.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
4.7.5.2.3. APPLICATION
4.7.5.2.4. TOP PLAYERS & KEY PRODUCTS
4.7.5.2.5. REGIONAL ANALYSIS 2014-2022 ($ MILLION)
4.7.5.2.6. KEY CONCLUSIONS
4.7.5.3. WEB-BASED CLINICAL DECISION SUPPORT SYSTEMS
4.7.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.7.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
4.7.5.3.3. APPLICATION
4.7.5.3.4. TOP PLAYERS & KEY PRODUCTS
4.7.5.3.5. REGIONAL ANALYSIS 2014-2022 ($ MILLION)
4.7.5.3.6. KEY CONCLUSIONS
5. COMPETITIVE LANDSCAPE
5.1. KEY STRATEGIES
5.1.1. LIST OF M&A
5.1.2. LIST OF JV
5.1.3. LIST OF PRODUCT LAUNCHES
5.1.4. LIST OF PARTNERSHIP
5.2. TOP 10 COMPANY ANALYSIS
6. GEOGRAPHICAL ANALYSIS
6.1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
6.2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
6.3. OPPORTUNITY MATRIX
6.4. GLOBAL ENHANCED OIL RECOVERY MARKET BY REGION 2014-2022 ($ MILLION)
6.4.1. NORTH AMERICA
6.4.1.1. INDUSTRIAL APPLICATION ANALYSIS 2014-2022 ($ MILLION)
6.4.1.2. TOP COUNTRY ANALYSIS
6.4.1.2.1. U.S.
6.4.1.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
6.4.1.2.1.2. TOP PLAYERS & KEY PRODUCTS
6.4.1.2.1.3. KEY CONCLUSIONS
6.4.1.2.2. CANADA
6.4.1.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
6.4.1.2.2.2. TOP PLAYERS & KEY PRODUCTS
6.4.1.2.2.3. KEY CONCLUSIONS
6.4.2. EUROPE
6.4.2.1. INDUSTRY APPLICATION ANALYSIS 2014-2022 ($ MILLION)
6.4.2.2. TOP COUNTRY ANALYSIS
6.4.2.2.1. UK
6.4.2.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
6.4.2.2.1.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.1.3. KEY CONCLUSIONS
6.4.2.2.2. FRANCE
6.4.2.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
6.4.2.2.2.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.2.3. KEY CONCLUSIONS
6.4.2.2.3. GERMANY
6.4.2.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
6.4.2.2.3.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.3.3. KEY CONCLUSIONS
6.4.2.2.4. RUSSIA
6.4.2.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
6.4.2.2.4.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.4.3. KEY CONCLUSIONS
6.4.2.2.5. REST OF EUROPE
6.4.2.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
6.4.2.2.5.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.5.3. KEY CONCLUSIONS
6.4.3. ASIA PACIFIC
6.4.3.1. INDUSTRY APPLICATION ANALYSIS 2014-2022 ($ MILLION)
6.4.3.2. TOP COUNTRY ANALYSIS
6.4.3.2.1. CHINA
6.4.3.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
6.4.3.2.1.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.1.3. KEY CONCLUSIONS
6.4.3.2.2. INDIA
6.4.3.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
6.4.3.2.2.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.2.3. KEY CONCLUSIONS
6.4.3.2.3. JAPAN
6.4.3.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
6.4.3.2.3.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.3.3. KEY CONCLUSIONS
6.4.3.2.4. AUSTRALIA
6.4.3.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
6.4.3.2.4.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.4.3. KEY CONCLUSIONS
6.4.3.2.5. REST OF ASIA PACIFIC
6.4.3.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
6.4.3.2.5.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.5.3. KEY CONCLUSIONS
6.4.4. ROW
6.4.4.1. INDUSTRY APPLICATION ANALYSIS 2014-2022 ($ MILLION)
6.4.4.2. TOP COUNTRY ANALYSIS
6.4.4.2.1. LATIN AMERICA
6.4.4.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
6.4.4.2.1.2. TOP PLAYERS & KEY PRODUCTS
6.4.4.2.1.3. KEY CONCLUSIONS
6.4.4.2.2. MIDDLE EAST & AFRICA
6.4.4.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
6.4.4.2.2.2. TOP PLAYERS & KEY PRODUCTS
6.4.4.2.2.3. KEY CONCLUSIONS
7. COMPANY PROFILES
7.1. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.
7.1.1. OVERVIEW
7.1.2. PRODUCT PORTFOLIO
7.1.3. KEY INNOVATION/FOCUS SECTOR
7.1.4. STRATEGIC INITIATIVES
7.1.5. SCOT ANALYSIS
7.2. CERNER CORPORATION
7.2.1. OVERVIEW
7.2.2. PRODUCT PORTFOLIO
7.2.3. KEY INNOVATION/FOCUS SECTOR
7.2.4. STRATEGIC INITIATIVES
7.2.5. SCOT ANALYSIS
7.3. ELSEVIER B.V. (A DIVISION OF THE RELX GROUP)
7.3.1. OVERVIEW
7.3.2. PRODUCT PORTFOLIO
7.3.3. KEY INNOVATION/FOCUS SECTOR
7.3.4. STRATEGIC INITIATIVES
7.3.5. SCOT ANALYSIS
7.4. EPIC SYSTEMS CORPORATION
7.4.1. OVERVIEW
7.4.2. PRODUCT PORTFOLIO
7.4.3. KEY INNOVATION/FOCUS SECTOR
7.4.4. STRATEGIC INITIATIVES
7.4.5. SCOT ANALYSIS
7.5. GENERAL ELECTRIC COMPANY
7.5.1. OVERVIEW
7.5.2. PRODUCT PORTFOLIO
7.5.3. KEY INNOVATION/FOCUS SECTOR
7.5.4. STRATEGIC INITIATIVES
7.5.5. SCOT ANALYSIS
7.6. IBM CORPORATION
7.6.1. OVERVIEW
7.6.2. PRODUCT PORTFOLIO
7.6.3. KEY INNOVATION/FOCUS SECTOR
7.6.4. STRATEGIC INITIATIVES
7.6.5. SCOT ANALYSIS
7.7. INTERNATIONAL BUSINESS MACHINE (IBM) CORPORATION
7.7.1. OVERVIEW
7.7.2. PRODUCT PORTFOLIO
7.7.3. KEY INNOVATION/FOCUS SECTOR
7.7.4. STRATEGIC INITIATIVES
7.7.5. SCOT ANALYSIS
7.8. MCKESSON CORPORATION
7.8.1. OVERVIEW
7.8.2. PRODUCT PORTFOLIO
7.8.3. KEY INNOVATION/FOCUS SECTOR
7.8.4. STRATEGIC INITIATIVES
7.8.5. SCOT ANALYSIS
7.9. MEDITECH
7.9.1. OVERVIEW
7.9.2. PRODUCT PORTFOLIO
7.9.3. KEY INNOVATION/FOCUS SECTOR
7.9.4. STRATEGIC INITIATIVES
7.9.5. SCOT ANALYSIS
7.10. PHILIPS HEALTHCARE
7.10.1. OVERVIEW
7.10.2. PRODUCT PORTFOLIO
7.10.3. KEY INNOVATION/FOCUS SECTOR
7.10.4. STRATEGIC INITIATIVES
7.10.5. SCOT ANALYSIS
7.11. RELX GROUP PLC
7.11.1. OVERVIEW
7.11.2. PRODUCT PORTFOLIO
7.11.3. KEY INNOVATION/FOCUS SECTOR
7.11.4. STRATEGIC INITIATIVES
7.11.5. SCOT ANALYSIS
7.12. SIEMENS AG
7.12.1. OVERVIEW
7.12.2. PRODUCT PORTFOLIO
7.12.3. KEY INNOVATION/FOCUS SECTOR
7.12.4. STRATEGIC INITIATIVES
7.12.5. SCOT ANALYSIS
7.13. THERMO SCIENTIFIC
7.13.1. OVERVIEW
7.13.2. PRODUCT PORTFOLIO
7.13.3. KEY INNOVATION/FOCUS SECTOR
7.13.4. STRATEGIC INITIATIVES
7.13.5. SCOT ANALYSIS
7.14. WOLTERS KLUWER HEALTH
7.14.1. OVERVIEW
7.14.2. PRODUCT PORTFOLIO
7.14.3. KEY INNOVATION/FOCUS SECTOR
7.14.4. STRATEGIC INITIATIVES
7.14.5. SCOT ANALYSIS
7.15. ZYNX HEALTH
7.15.1. OVERVIEW
7.15.2. PRODUCT PORTFOLIO
7.15.3. KEY INNOVATION/FOCUS SECTOR
7.15.4. STRATEGIC INITIATIVES
7.15.5. SCOT ANALYSIS
LIST OF TABLES
GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET BY COMPONENT ($ MILLION)
GLOBAL SERVICES SYSTEM BY GEOGRAPHY ($ MILLION)
GLOBAL SOFTWARE SYSTEM BY GEOGRAPHY ($ MILLION)
GLOBAL HARDWARE SYSTEM BY GEOGRAPHY ($ MILLION)
GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET BY DELIVERY MODE ($ MILLION)
GLOBAL CLOUD-BASED CLINICAL DECISION SUPPORT SYSTEM BY GEOGRAPHY ($ MILLION)
GLOBAL ON-PREMISE CLINICAL DECISION SUPPORT SYSTEM BY GEOGRAPHY ($ MILLION)
GLOBAL WEB-BASED CLINICAL DECISION SUPPORT SYSTEM BY GEOGRAPHY ($ MILLION)
GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET BY PRODUCT($ MILLION)
GLOBAL INTEGRATED CLINICAL DECISION SUPPORT SYSTEM BY GEOGRAPHY ($ MILLION)
GLOBAL STANDALONE CLINICAL DECISION SUPPORT SYSTEM BY GEOGRAPHY ($ MILLION)
GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET BY TYPE ($ MILLION)
GLOBAL DIAGNOSTIC CLINICAL DECISION SUPPORT SYSTEM BY GEOGRAPHY ($ MILLION)
GLOBAL THERAPEUTIC CLINICAL DECISION SUPPORT SYSTEM BY GEOGRAPHY ($ MILLION)
GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET BY MODEL ($ MILLION)
GLOBAL KNOWLEDGE-BASED CLINICAL DECISION SUPPORT SYSTEM BY GEOGRAPHY ($ MILLION)
GLOBAL NON-KNOWLEDGE-BASED CLINICAL DECISION SUPPORT SYSTEM BY GEOGRAPHY ($ MILLION)
GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET BY USER INTERACTIVITY ($ MILLION)
GLOBAL ACTIVE CLINICAL DECISION SUPPORT SYSTEMS BY GEOGRAPHY ($ MILLION)
GLOBAL PASSIVE CLINICAL DECISION SUPPORT SYSTEMS BY GEOGRAPHY ($ MILLION)
GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET BY APPLICATION ($ MILLION)
GLOBAL ADVANCED CLINICAL DECISION SUPPORT SYSTEMS BY GEOGRAPHY ($ MILLION)
GLOBAL CONVENTIONAL CLINICAL DECISION SUPPORT SYSTEMS BY GEOGRAPHY ($ MILLION)
NORTH AMERICA CLINICAL DECISION SUPPORT SYSTEM MARKET ($ MILLION)
EUROPE CLINICAL DECISION SUPPORT SYSTEM MARKET ($ MILLION)
ASIA PACIFIC CLINICAL DECISION SUPPORT SYSTEM MARKET ($ MILLION)
REST OF THE WORLD CLINICAL DECISION SUPPORT SYSTEM MARKET ($ MILLION)
LIST OF FIGURES
GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET BY CONVENTIONAL CLINICAL DECISION SUPPORT SYSTEM MARKET $ MILLION)
GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET BY ADVANCED CLINICAL DECISION SUPPORT SYSTEMS MARKET $ MILLION)
GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET BY PASSIVE CLINICAL DECISION SUPPORT SYSTEMS MARKET $ MILLION)
GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET BY ACTIVE CLINICAL DECISION SUPPORT SYSTEMS MARKET $ MILLION)
GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET BY NON-KNOWLEDGE-BASED CLINICAL DECISION SUPPORT SYSTEM MARKET $ MILLION)
GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET BY KNOWLEDGE-BASED CLINICAL DECISION SUPPORT SYSTEM MARKET $ MILLION)
GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET BY THERAPEUTIC CLINICAL DECISION SUPPORT SYSTEM MARKET $ MILLION)
GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET BY DIAGNOSTIC CLINICAL DECISION SUPPORT SYSTEM MARKET $ MILLION)
GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET BY INTEGRATED CLINICAL DECISION SUPPORT SYSTEM MARKET $ MILLION)
GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET BY STANDALONE CLINICAL DECISION SUPPORT SYSTEM MARKET $ MILLION)
GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET BY WEB-BASED CLINICAL DECISION SUPPORT SYSTEM MARKET $ MILLION)
GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET BY ON-PREMISE CLINICAL DECISION SUPPORT SYSTEM MARKET $ MILLION)
GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET BY CLOUD-BASED CLINICAL DECISION SUPPORT SYSTEM MARKET $ MILLION)
GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET BY SOFTWARE MARKET $ MILLION)
GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET BY HARDWARE MARKET $ MILLION)
GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET BY SERVICES MARKET $ MILLION)
UNITED STATES (U.S.) CLINICAL DECISION SUPPORT SYSTEM MARKET ($ MILLION)
CANADA CLINICAL DECISION SUPPORT SYSTEM MARKET ($ MILLION)
UNITED KINGDOM (UK) CLINICAL DECISION SUPPORT SYSTEM MARKET ($ MILLION)
FRANCE CLINICAL DECISION SUPPORT SYSTEM MARKET ($ MILLION)
GERMANY CLINICAL DECISION SUPPORT SYSTEM MARKET ($ MILLION)
SPAIN CLINICAL DECISION SUPPORT SYSTEM MARKET ($ MILLION)
ITALY CLINICAL DECISION SUPPORT SYSTEM MARKET ($ MILLION)
ROE CLINICAL DECISION SUPPORT SYSTEM MARKET ($ MILLION)
INDIA CLINICAL DECISION SUPPORT SYSTEM MARKET ($ MILLION)
CHINA CLINICAL DECISION SUPPORT SYSTEM MARKET ($ MILLION)
JAPAN CLINICAL DECISION SUPPORT SYSTEM MARKET ($ MILLION)
KOREA CLINICAL DECISION SUPPORT SYSTEM MARKET ($ MILLION)
AUSTRALIA CLINICAL DECISION SUPPORT SYSTEM MARKET ($ MILLION)
ROAPAC CLINICAL DECISION SUPPORT SYSTEM MARKET ($ MILLION)
LATIN AMERICA CLINICAL DECISION SUPPORT SYSTEM MARKET ($ MILLION)
MENA CLINICAL DECISION SUPPORT SYSTEM MARKET 2014-2022 ($ MILLION)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report